Case Reports

Section Edited by Alfred Zippelius, MD

Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept

Lee S Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, Baptiste Abbar, Bruno Pinna, Yves Allenbach, Jean-Paul Mira, Javid Moslehi, Michelle Rosenzwajg, Joe-Elie Salem

10.1136/jitc-2022-004699

April 5, 2022

Spontaneous tumor regression following COVID-19 vaccination

Luana Guimaraes de Sousa, Daniel J McGrail, Kaiyi Li, Mario L Marques-Piubelli, Cipriano Gonzalez, Hui Dai, Sammy Ferri-Borgogno, Myrna Godoy, Jared Burks, Shiaw-Yih Lin, Diana Bell, Renata Ferrarotto

10.1136/jitc-2021-004371

March 3, 2022

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission

Tejus Satish, Shaheer Khan, Matt Levin, Richard Carvajal, Angela J Yoon

10.1136/jitc-2020-001219

October 29, 2021

Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report

Paul Sackstein, Jacob Zaemes, Chul Kim

10.1136/jitc-2021-002855

July 30, 2021

Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report

Rebecca Baur, Regina Jitschin, Soraya Kharboutli, Andrej Stoll, Simon Völkl, Maike Büttner-Herold, Daniela Schmidt, Wolf Rösler, Andreas Mackensen, Dimitrios Mougiakakos

10.1136/jitc-2021-002721

July 16, 2021

Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab

Sang T. Kim, Jean Tayar, Siqing Fu, Danxia Ke, Elliot Norry, Amy Sun, Juli Miller, David S. Hong

10.1136/jitc-2021-002716

July 7, 2021

Evaluating T-cell cross-reactivity between tumors and immune-related adverse events with TCR sequencing: pitfalls in interpretations of functional relevance

Tricia Cottrell, Jiajia Zhang, Boyang Zhang, Genevieve J Kaunitz, Poromendro Burman, Hok-Yee Chan, Franco Verde, Jody E Hooper, Hans Hammers, Mohamad E Allaf, Hongkai Ji, Janis Taube, Kellie N Smith

10.1136/jitc-2021-002642

July 6, 2021

Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures

Laurene S Cheung, Lingling Chen, Teniola F Oke, Thomas B Schaffer, Karim Boudadi, Jillian T Ngo, John McMahon Gross, Holly Kemberling, Luis A Diaz, Evan Lipson, John-WIlliam Sidhom, Janis Taube, Robert Anders, Drew M Pardoll, Dung T Le, Christian F Meyer, Nicolas Llosa

10.1136/jitc-2021-002345

June 8, 2021

T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab

Sean Hammond, Anna Olsson-Brown, Joshua Gardner, Paul Thomson, Serat-E Ali, Carol Jolly, Dan Carr, Lorenzo Ressel, Munir Pirmohamed, Dean Naisbitt

10.1136/jitc-2021-002521

May 28, 2021

Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy

Chao Zhang, Kai Yin, Si-Yang Liu, Li-Xu Yan, Jian Su, Yi-Long Wu, Xu-Chao Zhang, Wen-Zhao Zhong, Xue-Ning Yang

10.1136/jitc-2020-002312

April 5, 2021